Plasma proteomic analysis of pancreatic cancer by 2-dimensional gel electrophoresis

被引:21
作者
Deng, Ruixue
Lu, Zhaohui
Chen, Yuanjia
Zhou, Lu
Lu, Xinghua
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gastroenterol, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China
[3] Peking Union Med Coll, Beijing, Peoples R China
关键词
pancreatic cancer; protein profile; plasma; chronic pancreatitis; 2-dimensional gel electrophoresis;
D O I
10.1097/MPA.0b013e31802f2483
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: Late diagnosis is the major reason for poor prognosis of pancreatic cancer (PC). Developing new biomarkers of early stage detection is critical. Methods: Proteomic analysis with 2-dimensional gel electrophoresis was used to identify differentially expressed proteins in plasma of PC patients. The 2-dimensional gel electrophoresis plasma protein profiles of 11 PC patients (preoperative and postoperative) were compared with those of 10 patients with chronic pancreatitis (CP) and 11 healthy controls. Results: Five proteins were found to be constantly changed. Haptoglobin (Hp) (3 chain and leucine-rich alpha(2) glycoprotein upregulated slightly in PC plasma. Pancreatic cancer had a higher frequency of Hp2-2 phenotype but lacked Hp1-1 phenotype. Hemoglobin was increased significantly in plasma samples of PC and CP. alpha(1) Antitrypsin gradually increased its expression level in healthy control, PC, and CP. Immunoglobin J chain was elevated in CP plasma samples. Haptoglobin, al antitrypsin, and leucine-rich alpha(2)-glycoprotein were all greatly elevated after tumor resection in PC patients. Conclusions: Proteomic analysis can simultaneously detect changes of multiproteins in plasma of PC, but detected proteins are abundant and common plasma proteins and their diagnostic value may be limited.
引用
收藏
页码:310 / 317
页数:8
相关论文
共 47 条
[31]  
OH SK, 1987, CANCER RES, V47, P5120
[32]   Cancer statistics, 1996 [J].
Parker, SL ;
Tong, T ;
Bolden, S ;
Wingo, PA .
CA-A CANCER JOURNAL FOR CLINICIANS, 1996, 46 (01) :5-27
[33]   Determination of protein markers in human serum:: Analysis of protein expression in toxic oil syndrome studies [J].
Quero, C ;
Colomé, N ;
Prieto, MR ;
Carrascal, M ;
Posada, M ;
Gelpi, E ;
Abian, J .
PROTEOMICS, 2004, 4 (02) :303-315
[34]  
Rosty C, 2002, CANCER RES, V62, P1868
[35]   Early detection of pancreatic carcinoma [J].
Rosty, C ;
Goggins, M .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2002, 16 (01) :37-+
[36]   ALPHA-1-ANTITRYPSIN LEVELS AND PHENOTYPES AND HEPATITIS-B SEROLOGY IN LIVER-CANCER [J].
SPAROS, L ;
TOUNTAS, Y ;
CHAPUISCELLIER, C ;
THEODOROPOULOS, G ;
TRICHOPOULOS, D .
BRITISH JOURNAL OF CANCER, 1984, 49 (05) :567-570
[37]   PERIODICITY OF LEUCINE AND TANDEM REPETITION OF A 24-AMINO ACID SEGMENT IN THE PRIMARY STRUCTURE OF LEUCINE-RICH ALPHA-2-GLYCOPROTEIN OF HUMAN-SERUM [J].
TAKAHASHI, N ;
TAKAHASHI, Y ;
PUTNAM, FW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (07) :1906-1910
[38]  
THOMPSON DK, 1983, CANCER, V51, P2100, DOI 10.1002/1097-0142(19830601)51:11<2100::AID-CNCR2820511124>3.0.CO
[39]  
2-J
[40]   ALPHA-1-ANTITRYPSIN AND CANCER OF THE PANCREAS [J].
TOUNTAS, Y ;
SPAROS, L ;
THEODOROPOULOS, C ;
TRICHOPOULOS, D .
DIGESTION, 1985, 31 (01) :37-40